Cannabis for Chronic Pain: How Large the Benefit Actually Is
Does cannabis work for chronic pain, and by how much? Across 32 randomized trials in 5,174 adults, non-inhaled medical cannabis produced a small improvement in pain, a very small improvement in physical function, and a small improvement in sleep, with…
Emerging Cannabinoid Biosensor Technology for Pain Management
Cannabinoid biosensor technology is evolving to support pain management by enabling measurement of THC and CBD levels. Portable biosensors show promise for point-of-care testing, but most remain unvalidated for clinical use. This review highlights the…
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
A new Minnesota medical cannabis study highlights medical cannabis chronic pain function by showing improvements in life enjoyment and daily activity. Many chronic pain patients report better function alongside pain score changes. This observational data…
How Many CBD Gummies Should I Eat for Pain
Proper CBD gummy dosing for pain management requires understanding bioavailability, individual variability, and systematic titration protocols. Clinical evidence supports starting with 2.5-5mg twice daily and gradual dose escalation. This guide provides…
Cannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug.
Recent research demonstrates that metamizol/dipyrone exhibits cannabinoid effects in pediatric anesthesia applications, revealing endocannabinoid system interactions. This study provides mechanistic insights into how this vintage analgesic may achieve…
Effects and mechanisms of cannabidiol in attenuating orofacial inflammatory pain and ameliorating pain-related affective deficits.
A new preclinical study found that cannabidiol orofacial inflammatory pain study showed promising results in reducing both sensory and emotional aspects of facial pain in laboratory mice. While encouraging for future research directions, these animal…
Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People With Multiple Sclerosis.
A real-time smartphone-based study of 258 MS patients revealed that higher pain levels drive increased cannabis use and decreased alcohol consumption. This research using ecological momentary assessment provides clinical evidence that MS patients make…
Attitudes, beliefs and willingness to prescribe medical cannabis among public medical practitioners in Malaysia.
A nationwide survey of Malaysian physicians reveals measured acceptance of medical cannabis, with 65% supporting availability for certain conditions. The strongest support emerged for pain management applications, where 87% of doctors endorsed medical…
A qualitative study on cannabis use for harm reduction and pain among veterans enrolled in an SUD treatment program.
A qualitative study reveals how veterans with substance use disorders view cannabis for veteran chronic pain management. Veterans reported using cannabis to manage chronic pain, anxiety, and sleep issues during addiction treatment. This research…
Patient perspectives on non‑traumatic painful upper‑extremity conditions, co-occurring risky substance use, and an integrated web-based mind-body intervention addressing both conditions.
Recent qualitative research examining upper extremity pain and substance use management reveals patients commonly use alcohol, cannabis, and tobacco for symptom relief but lack awareness of pain-substance interactions. The study provides insights for…